Abstract
Initial clinical uses of hyperbaric oxygen (HBO2) capitalized upon physical effects to drive offending gases back into solution and deliver more oxygen to tissues in early treatments of decompression sickness. HBO2 has a myriad of other effects, including stimulating angiogenesis and new cellular in growth for healing.
HBO2 Applied to Patients with Osteoradionecrosis of the Mandible
As incremental improvements in head and neck cancers improved survival with better surgical techniques for more complete tumor extirpation plus better radiation for enhanced local control and even further adjuvant therapies that increased long term survival, patients began living long enough to suffer all the sequelae of osteoradionecrosis (ORN) of the mandible. Patients who had otherwise been cured of their original cancer now suffered ever worsening dentition, including loosening and loss of teeth, and even pathological jaw fractures. These seriously impacted their quality of life for eating, speech, social isolation with open draining sockets, problematic and malodorous wounds and exposed bone and pain.1,2 As more of these challenging patients presented, it was easy to assume that the exposed bone and soft tissue problems were related to chronic colonization and then resultant infections due to the inherently high bacterial counts in the mouth. Although increasingly stronger antibiotic regimens and surgical dental and bone stabilization protocols were instituted many patients still suffered less than optimal outcomes thought to be related to variants of osteomyelitis of the mandible.3 At the same time, HBO2 was accumulating data that high oxygen tensions were toxic to certain bacteria, such as clostridia species, and might also have other cellular effects for better healing in ORN.4
Real HBO2 Effects Irradiated Tissue worked out in ORN and then in other Tissues
This led to an oral surgeon, Dr. Robert E Marx, and others to study if HBO2 could synergistically improve antibiotic control of surgical complications in ORN.5,6 Fortunately, in the effort to study the bacterial loads, the pathological bone specimens were carefully analyzed in the course of these trials that included prospective, randomized arms both with and without HBO2. Although it was expected that those receiving HBO2 would have lower bacterial counts, lower amounts of bacteria in the bone, and less culturing of bacteria causing problems for healing, there was a different serendipitous finding: the bone samples in the HBO2 arms all had increased densities of new blood vessels and in growth of cells that were not present before treatment.7, 8, 9, 10 HBO2 was having an effect on infection and bone breakdown from stimulating neo-angiogenesis in the bone which allowed the bone to tolerate further surgical manipulation and heal. This was and continues to be a paradigm shift in patient’s care after medical irradiation.11, 12 A process, radiation-induced tissue fibrosis and its hypo-vascularity, was being offset by the stimulatory effects of HBO2.13, 14
By stimulating new blood vessel and cellular in growth, this increased blood flow to allow the bone and soft tissues to heal. This gave head, neck, and oral surgeons increased capabilities and lower incidences of complications for patients. These neo-angiogenesis effects have later been better demonstrated with an array of cellular and cytokine effects and form a more modern way of looking at how HBO2 treats not only ORN of the mandible,15,16 but also for laryngeal and soft tissue necrosis in the head and neck17,18 chest wall necrosis and post breast cancer irradiation syndromes,19 radiation cystitis20 radiation proctitis, rads enteritis, and pelvis floor organs including the vagina21 and neural tissues and the brain.22,23
All of these radiation injury effects can be have HBO2 to augment therapeutic responses for the patient. The effects of radiation can be early or delayed, but should a patient with skin, soft tissue including intra-oral or other mucosal surfaces (urogenital or GI)24, bony, or neural tissue are symptomatically changing after irradiation, then adjunctive HBO2 can be considered.25 In many ways the radiation induced hypovascularity is similar to the diabetes mellitus induced hypovascularity where HBO2 has also been shown to be beneficial where the cycling of hypoxia (while in the HBO2 chamber) and then the slow decay back to baseline hypoxia after treatment is stimulatory for neoangiogenesis.26
With the advent of ever larger data registries, more applications of HBO2 for radiation-induced changes are accumulating. As in other non-healing applications for adjunctive HBO2 better data will optimize practice guidelines, documented efficacies and also allay some safety concerns as many post irradiated patients may be at risk for tumor recurrence regardless of any HBO2 offered. Although to date, there is no accumulated evidence for increased cancer recurrences with HBO2.27,28 In fact, especially for head and neck cancers, further tracking of recurrences is demonstrating specific differences in tumor biology that predict cancer re-growth such that better HBO2 tracking may contribute to finding patients at risk for cancer recurrences.29
Conclusions
Irradiated tissue responses well delineated in hyperbaric ORN studies are a more modern conceptualization of HBO2 effects and potential value to patients. As ever increasing sophistication of basic science capabilities to delineate cellular and tissue responses occur, HBO2 has been found to have effects beyond oxygenation. As HBO2 increases tissue oxygenation and improves blood flow, it also effects cellular responses for healing.30 However interesting these basic science mechanism are to consider, modern evidence based recommendations are also based upon clinical evidence and this is where better data registries will make an impact. The cumulative patient and tissue improvements seen in ORN and other post irradiation changes demonstrate the additional, adjunctive value of HBO2 in other similarly damaged tissue states.
Figure 1.
Healed to clean dry scabs, hyperbaric sequence completed at 40 treatments.
Footnotes
John P. Kirby MD, FACS, is the Director of Wound Healing Programs, Associate Professor of Surgery, Section of Acute and Critical Care Surgery, at Washington University School of Medicine, Barnes-Jewish Hospital, in St. Louis, Missouri.
Contact: kirbyj@wustl.edu
Disclosure
None reported.
References
- 1.Johnson P. Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases. [Discussion] J Oral Maxillofac Surg. 1997;55(6):545–6. doi: 10.1016/s0278-2391(97)90478-x. [DOI] [PubMed] [Google Scholar]
- 2.Dorr W, Hendry H. Consequential lae effects in normal tissues. Radiother Oncol. 2001;61:223–231. doi: 10.1016/s0167-8140(01)00429-7. [DOI] [PubMed] [Google Scholar]
- 3.Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283–288. doi: 10.1016/0278-2391(83)90294-x. [DOI] [PubMed] [Google Scholar]
- 4.Kraut RA. Prophylactic hyperbaric oxygen to avoid osteoradionecrosis when extractions follow radiation therapy. Clin Prev Dent. 1985;7(5):17–20. [PubMed] [Google Scholar]
- 5.Marx RE. Osteoradionecrosis of jaws: review and update. Hyperbaric Oxygen Rev. 1984;12(5):78–128. [Google Scholar]
- 6.Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111(1):49–54. doi: 10.14219/jada.archive.1985.0074. [DOI] [PubMed] [Google Scholar]
- 7.Mounsey RA, Brown DH, O’Dwyer TP, Gullane PJ, Koch GH. Role of hyperbaric oxygen therapy in the management of mandibular osteoradionecrosis. Laryngoscope. 1993;103(6):605–8. doi: 10.1288/00005537-199306000-00005. [DOI] [PubMed] [Google Scholar]
- 8.Lambert PM, Intriere N, Eichstaedt R. Clinical controversies in oral and maxillofacial surgery. Part one. Management of dental extractions in irradiated jaws: a protocol with hyperbaric oxygen therapy. J Oral Maxillofac Surg. 1997;55(3):268–74. doi: 10.1016/s0278-2391(97)90541-3. [DOI] [PubMed] [Google Scholar]
- 9.Aitasalo K, Grenman R, Virolainen E, Niinikoski J, Klossner J. A modified protocol to treat early osteoradionecrosis of the mandible. Undersea Hyperb Med. 1995;22(2):161–70. [PubMed] [Google Scholar]
- 10.Brown DA, Evans AW, Sandor GK. Hyperbaric oxygen therapy in the management of osteoradionecrosis of the mandible. Adv Otorhinolaryngology. 1998;54:14–32. doi: 10.1159/000059051. [DOI] [PubMed] [Google Scholar]
- 11.Marx RE, Johnson RP. Problem wounds in oral and maxillofacial surgery: The role of hyperbaric oxygen. In: Davis JC, Hunt TK, editors. Problem wounds — the role of oxygen. Elsevier; New York: 1988. pp. 65–123. [Google Scholar]
- 12.Nilsson P, Albrektsson T, Granstrom G, Rockert HO. The effect of hyperbaric oxygen treatment on bone regeneration: an experimental study using the bone harvest chamber in the rabbit. Int J Oral Maxillofac Implants. 1988;3(1):43–8. [PubMed] [Google Scholar]
- 13.Sawai T, Niimi A, Takahashi H, Ueda M. Histologic study of the effect of hyperbaric oxygen therapy on autogenous free bone grafts. J Oral Maxillofac Surg. 1996;54(8):975–81. doi: 10.1016/s0278-2391(96)90396-1. [DOI] [PubMed] [Google Scholar]
- 14.Denham J, Hauer-Jensen M. The radiotherapeutic inury—a complex “wound”. Radiother Oncol. 2022;63:129–145. doi: 10.1016/s0167-8140(02)00060-9. [DOI] [PubMed] [Google Scholar]
- 15.Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol. 2009;106 doi: 10.1152/japplphysiol.91004.2008. 988995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Thom SR. Hyperbaric Oxygen: its mechanisms and efficacy. Plast Reconst Surgery. 2011;127(Suppl 1):1315–1415. doi: 10.1097/PRS.0b013e3181fbe2bf. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hampson NB, Holm JR, Wreford-Brown CE, Feldmeier JJ. Prospective assessment of outcome in 411 patients treated with hypobaric oxygen for chgrnic radiation issue injury. Cancer. 2012;118:3860–3868. doi: 10.1002/cncr.26637. [DOI] [PubMed] [Google Scholar]
- 18.Maier A, Gaggl A, Klemen H, Santler G, Anegg U, Fell B, et al. Review of severe osteoradionecrosis treated by surgery alone or surgery with postoperative hyperbaric oxygenation. Br J Oral Maxillofac Surg. 2000;38(3):173–6. doi: 10.1054/bjom.1999.0285. [DOI] [PubMed] [Google Scholar]
- 19.Feldmeier JJ, Heimbach RD, Davolt DA, et al. Hyperbaric oxygen as an adjunctive treatment for delayed radiation injury of the chest wall: a retrospective review of 23 cases. Undersea Hyperb Med. 1995;22:383–393. [PubMed] [Google Scholar]
- 20.Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002;29:4–30. [PubMed] [Google Scholar]
- 21.Fink D, Chetty N, et al. Hyperbaric oxygen therapy for delayed radiation injuries in gynecological cancers. Int J Genecol Cancer. 2006;16:638–642. doi: 10.1111/j.1525-1438.2006.00388.x. [DOI] [PubMed] [Google Scholar]
- 22.Schultieiss TE, Stephaen LC, Peters LJ. Survival in radiation myelopathy. Int J Radiat Oncol Biol Phys. 1986;12:1765–1769. doi: 10.1016/0360-3016(86)90317-2. [DOI] [PubMed] [Google Scholar]
- 23.Gesell LB, Warnick R, Breneman J, et al. Effectiveness of hyperbaric oxygen for the treatment of soft tissue radionecrosis of the brain. Underses Hyperbaric Medical Society Annual Scientific Meeting; June 28–30, 2002; San Diego CA. [Google Scholar]
- 24.Thorn JJ, Kallehave F, Westgaard P, Hansen EH, Gottrup F. The effect of hyperbaric oxygen on irradiated oral tissues: transmucosal oxygen tension measurements. J Oral Maxillofac Surg. 1997;55(10):1103–7. doi: 10.1016/s0278-2391(97)90290-1. [DOI] [PubMed] [Google Scholar]
- 25.Feldmeier JJ. In: Chapter 8: Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) in UHMS Hyperbaric Oxygen Therapy Indications. 13 the Ed. Weaver Lindell K., editor. Best Publishing; North Palm Beach FL: 2014. [Google Scholar]
- 26.Gallagher KA, Lie ZJ, et al. Dieabetic impairments in NO-mediated endothelial progenitor cell mobilization and homeing are reversed by hyperoxia and SDF-1alpha. J Clin Invest. 2007;117:1249–1259. doi: 10.1172/JCI29710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Feldmeier JJ, Heimbach RD, et al. Does hyperbaric oxygen have a cancer causing or promoting effect? A review of the pertinent literature. Undersea Hyperb Med. 1994;21:467–475. [PubMed] [Google Scholar]
- 28.Feldmeier JJ. Hyperbaric oxygen: does it have a cancer causing or growth enhancing effect. Proceedings of the consensus conference sponsored by the European Society for Therapeutic Radiology and Oncology and the European Committee for Hyperbaric Medicine; Portugal. 2001; pp. P129–146. [Google Scholar]
- 29.Lin H, Ku C, et al. Hyperbaric oxygen for late radiation-associated tissue necroses: is it safe in patients with loco-regionally recurrent and then successfully salvaged head and neck cancers? Int J Radiation Oncology Biol Phys. 2009;74(4):1077–1082. doi: 10.1016/j.ijrobp.2008.08.076. [DOI] [PubMed] [Google Scholar]
- 30.Goldstein LJ, Gallagher KA, Bauer SM, et al. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells. 2006;24:2309–2318. doi: 10.1634/stemcells.2006-0010. [DOI] [PubMed] [Google Scholar]


